Nucleus RadioPharma is a growing end-to-end contract development and manufacturing organization (CDMO) partner dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies so that radiopharmaceutical companies and other innovators can succeed.
Unlock your potentialUnder the rigorous scientific guidance of leading industry experts, we’re building the infrastructure radioligand therapy companies need to be successful at every stage to bring life-saving therapies from concept to reality.
We’re building a national manufacturing footprint that mitigates current bottlenecks to bring your radiotherapeutics to market—and closer to patients—faster without sacrificing quality.
Our first facility, located in Rochester, MN, is built to support our clients at every stage of the radiotherapy lifecycle—pre-clinical, clinical, and commercial.
Production is scheduled to begin in Q4 2024 at our newly opened Rochester, MN facility.
The potential for groundbreaking cancer treatments via targeted radiotherapies has grown, yet outdated processes and inefficiencies mar the path to bringing these solutions to market.
Our expert team is dedicated to helping innovators—whether you’re a biotech startup or a more established pharmaceutical organization—at every and any step of your journey to build robust and reliable clinical and commercial supply chains for targeted radiotherapies.
At Nucleus RadioPharma, our strength is the development and delivery of our client’s innovations. Our primary business objective is you—we don’t develop our own products. This singular focus allows us to put all of our efforts toward being a reliable and effective full-service CDMO partner.
